Back

Circulating ketone bodies in patients with acute heart failure treated with the SGLT2 inhibitor empagliflozin

23 May 2022 (17:16 - 17:25)
Organised by:
Congress Presentation Part of: Acute heartfailure from bench to bedside Pharmacotherapy HFA Premium Access Heart Failure 2022

About the speaker

Photo
Ms Suzanne Nathalie Voorrips

University Medical Centre Groningen, Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Coronary microvascular function in takotsubo syndrome
Doctor C. Ekenback (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Is heart failure associated with a worse prognosis than cancer? Five-year survival following hospitalization with heart failure.
Professor L. Fauchier (Tours, FR)
Abstract Slides Video
Presentation thumbnail
Distinct comorbidity clusters in patients with acute heart failure: data from RELAX-AHF-2
Miss K. Arevalo Gomez (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Hemodynamic impact of graded lower body negative pressure on left ventricular diastolic properties: a pressure volume study.
Mr L. Berboth (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
Phenotyping heart failure with a supranormal ejection fraction
Mr B. Van Essen (Groningen, NL)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heartfailure from bench to bedside
Video

The Event

Event poster

Heart Failure 2022

23 May 2022 17:16 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources